Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.

Wiegman CH, Michaeloudes C, Haji G, Narang P, Clarke CJ, Russell KE, Bao W, Pavlidis S, Barnes PJ, Kanerva J, Bittner A, Rao N, Murphy MP, Kirkham PA, Chung KF, Adcock IM, COPDMAP. · 2015

Read Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease. by Wiegman CH, Michaeloudes C, Haji G, Narang P, Clarke CJ, Russell KE, Bao W, Pavlidis S, Barnes PJ, Kanerva J, Bittner A, Rao N, Murphy MP, Kirkham PA, Chung KF, Adcock IM, COPDMAP. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4559140.txt.

Introduction

Coen H. Wiegman leads a twelve-author team linking damaged cell power units to lung disease, in The Journal of Allergy and Clinical Immunology in 2015. In chronic obstructive pulmonary disease, inflamed airways narrow and worsen over time. Oxidative stress, an overload of reactive oxygen, is a prime suspect, and the mitochondria that make energy are both source and victim of that stress.

Ozone-exposed mice developed lung inflammation, twitchy airways, and faulty mitochondria. Airway muscle cells from patients showed the same pattern, tied to remodeling of the airway wall. A mitochondria-targeted antioxidant, MitoQ, countered several of these effects in the tests. The work casts mitochondrial failure as a driver worth treating, not just a byproduct.

Catalog record

CREATORWiegman CH, Michaeloudes C, Haji G, Narang P, Clarke CJ, Russell KE, Bao W, Pavlidis S, Barnes PJ, Kanerva J, Bittner A, Rao N, Murphy MP, Kirkham PA, Chung KF, Adcock IM, COPDMAP.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4559140

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Oxidative stress–induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease By Coen H. Wiegman, Charalambos Michaeloudes, Gulammehdi Haji, Priyanka Narang, Colin J. Clarke, Kirsty E. Russell, Wuping Bao, Stelios Pavlidis, Peter J. Barnes, Justin Kanerva, Anton Bittner, Navin Rao Published in: The Journal of Allergy and Clinical Immunology DOI: 10.1016/j.jaci.2015.01.046 ABSTRACT Background Inflammation and oxidative stress play critical roles in patients with chronic obstructive pulmonary disease (COPD). Mitochondrial oxidative stress might be involved in driving the oxidative stress–induced pathology. Objective We sought to determine the effects of oxidative stress on mitochondrial function in the pathophysiology of airway inflammation in ozone-exposed mice and human airway smooth muscle (ASM) cells. Methods Mice were exposed to ozone, and lung inflammation, airway hyperresponsiveness (AHR), and mitochondrial function were determined. Human ASM cells were isolated from bronchial biopsy specimens from healthy subjects, smokers, and patients with COPD. Inflammation and mitochondrial function in mice and human ASM cells were measured with and without the presence of the mitochondria-targeted antioxidant MitoQ. Results Mice exposed to ozone, a source of oxidative stress, had lung inflammation and AHR associated with mitochondrial dysfunction and reflected by decreased mitochondrial membrane potential (ΔΨm), increased mitochondrial oxidative stress, and reduced mitochondrial complex I, III, and V expression. Reversal of mitochondrial dysfunction by the mitochondria-targeted antioxidant MitoQ reduced inflammation and AHR. ASM cells from patients with COPD have reduced ΔΨm, adenosine triphosphate content, complex expression, basal and maximum respiration levels, and respiratory reserve capacity compared with those from healthy control subjects, whereas mitochondrial reactive oxygen species (ROS) levels were increased. Healthy smokers were intermediate between healthy nonsmokers and patients with COPD. Hydrogen peroxide induced mitochondrial dysfunction in ASM cells from healthy subjects. MitoQ and Tiron inhibited TGF-β–induced ASM cell proliferation and CXCL8 release. Conclusions Mitochondrial dysfunction in patients with COPD is associated with excessive mitochondrial ROS levels, which contribute to enhanced inflammation and cell hyperproliferation. Targeting mitochondrial ROS represents a promising therapeutic approach in patients with COPD. Chronic obstructive pulmonary disease (COPD) is the third most common cause of death worldwide, mainly as a result of cigarette smoking in the developed world.1 COPD is characterized by chronic inflammation and development of airflow limitation caused by airway remodeling and destruction of lung tissue.1 Tobacco smoke induces local inflammation and enhances oxidative stress in the lung, affecting the oxidant-antioxidant balance, which is thought to be one of the major driving mechanisms in the development of COPD.2 Production of reactive oxygen species (ROS) in the mitochondria occurs as a byproduct of oxidative phosphorylation at the mitochondrial electron transport chain.3 Normally, ROS are cleared by the actions of antioxidants, such as glutathione, vitamins C and E, and enzymes, including catalases, peroxidases, and superoxide dismutases.4 Increased ROS levels or a reduction in antioxidant capacity can influence redox-sensitive cellular processes, including mitochondrial apoptosis.5 The primary function of mitochondria is to produce adenosine triphosphate (ATP), although they are also involved in other cellular functions, including redox homeostasis, ROS and nicotinamide adenine dinucleotide phosphate generation, calcium metabolism, and apoptosis.6 Mitochondria can also sense danger signals and induce inflammation by activating and controlling the innate immune system.7 Indeed, alterations in cellular metabolism have a profound effect on immunology and cell biology, particularly in patients with cancer in whom mitochondrial function is directly regulated by oncogenes and tumor suppressors and might be involved in oncogenic transformation.8 Genetic defects in mitochondrial function are associated with diseases, such as Leigh disease and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like syndrome.9 These diseases are associated with mitochondrial DNA mutations, which cause defects in respiratory chain function and energy production. Pathogenic mitochondrial DNA mutations are rare (1:10,000) and largely affect children.9 In addition, mitochondrial defects have been linked to diseases of aging resulting from exposure to oxidative stress.10 Airway wall remodeling in patients with COPD involves tissue repair and epithelial metaplasia, increased mucous metaplasia and submucosal gland hypertrophy, peribronchial fibrosis, and an increase in airway smooth muscle (ASM) mass.11 In addition to their contractile properties, ASM cells produce inflammatory mediators thought to drive, at least in part, the airway wall remodeling seen in patients with COPD.11 ASM cells from patients with COPD have a distinct phenotype compared with that of cells from healthy subjects.12 Specific therapies targeting ASM cells might be essential in treating airway remodeling in these patients. Ozone is an oxidizing environmental pollutant associated with worsening of symptoms in patients with asthma and COPD13 and increased morbidity and mortality rates in patients with cardiovascular and respiratory disorders.14,15 Ozone exposure in mice induces airway inflammation, airway hyperresponsiveness (AHR),16 and lung destruction similar to that observed in patients with COPD.17 Ozone has been hypothesized to initiate intracellular oxidative stress through formation of ozonide and hydrogen peroxide.18 In turn, these are able to produce ROS that can alter gene transcription through redox-mediated signaling pathways.19 We previously reported that acute and chronic exposure to ozone results in persistent inflammation and AHR, which are in part reversible by treatment with the antioxidant N-acetylcysteine (NAC).20,21 Here we show a marked alteration in mitochondrial function associated with increased inflammation and alterations in AHR in an ozone-induced animal model of COPD. In addition, there is abnormal mitochondrial function in ASM cells from patients with COPD, and this is induced by oxidative stress in ASM cells from healthy subjects. Antioxidants that are targeted to decrease mitochondrial oxidative damage specifically led to reduced inflammation and ASM proliferation. METHODS A more detailed description of the Methods can be found in this article's Online Repository at www.jacionline.org. Subjects This study was approved by the Ethics Committee of the Royal Brompton & Harefield Hospitals National Health Service Trust. All subjects provided written informed consent. Healthy nonsmokers (n = 15), healthy smokers (n = 10), and patients with COPD (n = 14) were recruited (Table I). In a separate study endobronchial biopsy specimens were obtained from 4 exsmokers with COPD and 4 healthy exsmokers matched for smoking history, age, and sex (Table II). Fiberoptic bronchoscopy and culture of ASM cells Spirometry was performed and lung function was recorded before bronchoscopy, as previously described.22 All subjects had bronchial biopsy specimens taken. ASM cells were isolated from bronchial biopsy specimens, as previously described.23 ASM cells were cultured in supplemented Dulbecco modified Eagle medium and used at passages 3 and 6. ASM cells were incubated in supplemented serum-free medium for 18 hours before experiments23 and used to measure various parameters of mitochondrial function. In other subjects intact mitochondria were isolated from fresh bronchial biopsy specimens, and membrane potential and mitochondrial ROS levels were measured. Mouse AHR and bronchoalveolar lavage Experiments were performed under a Project License from the British Home Office, United Kingdom, under the Animals (Scientific Procedures) Act 1986. Male C57BL/6 mice (6 weeks old; Harlan, Wyton, United Kingdom) were exposed to ozone (model 500 Ozoniser; Sander, Wuppertal, Germany) mixed with air (3-ppm concentration), as previously described.20,21 Lung function and AHR were measured and bronchoalveolar lavage (BAL) fluid and tissue collection was performed 24 hours after the last exposure.20,21 Resistance/compliance measures were obtained from tracheostomized and ventilated mice by using whole-body plethysmography (EMMS, Hants, United Kingdom), as previously described.20 Lung resistance (RL) was expressed as the percentage change from baseline RL with nebulized PBS (Sigma,

Read the complete text